Dr. Diana Hernandez is a stem cell biologist with more than 30 years’ experience in medical research and at least 12 years in the cell therapy field both in academia and industry. After several years in basic academic research at Imperial College and UCL, she has led several collaborative projects between academia and biotech. She currently leads a research team at Anthony Nolan, a charity established in 1974 as the first bone marrow register in the world. Her research focuses in improving the outcomes of patients undergoing bone marrow transplants by understanding the graft, and creating cell therapy products to treat relapse and GvHD. Diana is also the Vice-Chair of the Cell and Gene Therapy Advisory committee of the UK’s Bioindustries Association (BIA). Anthony Nolan administers the aligned UK bone marrow register, carries out research into stem cell transplant, has a series of programmes to help patients needing and undergoing stem cell transplantation and supports the cell and gene therapy industry by providing materials and services to advanced therapy developers.